<div id="readability-page-1">03:00 PM EST, 11/13/2025 (MT Newswires) -- WW International ( WW ) plans to offer Novo Nordisk's ( NVO ) Wegovy in pill form if it is launched in the US next year, Reuters reported Wednesday, citing WW CEO Tara Comonte.&#34;We have been working with Novo Nordisk ( NVO ) ahead of time to support the launch of oral weight-loss medication,&#34; Comonte was quoted as saying in an interview.&#34;A lot of people don't want an injection. And the convenience of a pill is going to be huge,&#34; she said.WW did not immediately respond to a request for comment from MT Newswires.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: 27.88, Change: +0.09, Percent Change: +0.34 MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

WW International plans to offer Novo Nordisk's Wegovy in pill form if launched in the US next year. CEO Tara Comonte highlighted the convenience of a pill over an injection. WW has been collaborating with Novo Nordisk to support the launch of this oral weight-loss medication. WW did not respond to MT Newswires' request for comment.

Market Chatter: WW Plans to Offer Wegovy Pill After Launch